Lung cancer is the leading causeof cancer-related death among men and women in the U.S. and worldwide. For manydecades, lung cancer was the sole cancer among the deadly four without anevidence-based screening method for decreasing mortality. This changed inNovember 2011, when findings from the National Lung Cancer Screening Trialshowed low-dose lung CT screening was more efficacious in reducing deaths inhigh-risk individuals than conventional radiography. As such, anever-increasing number of health organizations now recommend this screeningprotocol.
Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfillsthe dire need for a comprehensive guide explaining the crucial aspects of lungcancer screenings. The first two chapters lay a foundation with discussion oflung cancer epidemiology and risk factors beyond cigarette smoking. Subsequentchapters cover the fundamentals, with clinical pearls on setting up asuccessful lung cancer screening program, patient eligibility criteria, imagingvariances of tumors in the lungs, screening pros and cons, andinterpreting/reporting screening results.
The evolutionand future of lung cancer screenings
Detection andmanagement of unexpected incidental pulmonary and non-pulmonary findings
Discussion oftest cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chestCT screenings
Benefits andpotential harms associated with mass lung cancer screening programs includingfalse positive, false negative, and over-diagnosis rates
This state-of-the-art guide is essential reading forradiologists, oncologists, pulmonologists, and internists. It is a must-havebookshelf reference for hospital radiology and oncology departments, inparticular for those setting up new lung cancer screening programs.
No hay reseñas de clientes en este momento.
1 025,00 €